The STAT family of proteins in cytokine signaling

Progress in Biophysics and Molecular Biology

Volumn 71, Issue 3-4, 1999, Pages 405-422

  Shuai, Ke ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA BINDING PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL GROWTH; DIMERIZATION; GENE ACTIVATION; GROWTH REGULATION; HUMAN; IMMUNOREGULATION; INFLAMMATION; METABOLISM; PHYSIOLOGY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 0032921172     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0079-6107(98)00051-0     Document Type: Review

References (117)

1. Adams T.A., Hansen J.A., Starr R., Nicola N.A., Hilton D.J., Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273:1998;1285-1287.
2. Akira S., Nishio Y., Inoue M., Wang X., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF: a novel ISGF3 p91-regulated transcription factor involved in the gp130-mediated signaling pathway. Cell. 77:1994;63-71.
3. Aman J.M., Leonard W.J. Cytokine signaling: cytokine-inducible signaling inhibitors. Curr. Biol. 7:1997;R784-R788.
4. Beadling C., Ng J., Babbage J.W., Cantrell D.A. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15:1996;1902-1913.
5. Becker S., Groner B., Muller C.W. Three-dimensional structure of the Stat3b homodimer bound to DNA. Nature. 394:1998;145-151.
6. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A., Livingston D.M. Cooperation of Stat2 and p300/CBP in signaling induced by interferon-a. Nature. 383:1996;344-347.
7. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1:1998;619-625.
8. Boulton T.G., Zhong Z., Wen Z., Darnell J.E. Jr., Stahl N., Yancopoulos G.D. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modificatic nase. Natl. Acad. Sci. US. 92:1995;6915-6919.
9. Bright J.J., Kerr L.D., Sriram S. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T-lymphocytes. J. Immunol. 159:1997;175-183.
10. Chen X., Vinkemeier U., Zhao Y., Jeruzalmu D., Darnell J.E. Jr., Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell. 93:1998;827-839.
11. Chin Y.E., Kitagawa M., Su W.S., You Z.H., Iwamoto Y., Fu X.Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science. 272:1996;719-722.
12. Chin Y.E., Kitagawa M., Kuida K., Flavell R.A., Fu X.Y. Activation of the STAT signaling pathway can cause expression of capsase 1 and apoptosis. Mol. Cell. Biol. 17:1997;5237-5328.
13. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 278:1997;1803-1805.
14. Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17:1997;6508-6516.
15. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 79:1994;13-21.
16. Cohen G.B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 80:1995;237-248.
17. Darnell J.E. Jr., Kerr I.M., Stark G.M. JAK-STAT pathways and transcriptional activation in response to IFN's and other extracellular signaling proteins. Science. 264:1994;1415-1421.
18. Darnell J.E. Jr. STATs and gene regulation. Science. 277:1997;1630.
19. David M., Grimley P.M., Finbloom D.S., Larner A.C. A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol. Cell. Biol. 13:1993;7515-7521.
20. Decker T., Lew D.J., Mirkovitch J., Darnell J.E. Jr. Cytoplasmic activation of GAF, an IFN-gamma regulated DNA binding factor. EMBO J. 10:1991;927-932.
21. Deshaiis R.J. Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation. Trends Cell Biol. 5:1995;428-434.
22. Durbin J.E., Hackenmiller R., Simon M.C., Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:1996;443-450.
23. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
24. Fu X.-Y., Kessler D.S., Veals S.A., Levy D.E., Darnell J.E. Jr. ISGF3, the transcriptional activator induced by interferon-α, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA. 87:1990;8555-8559.
25. Fu X.-Y. A trascriptional factor with SH2 and SH3 domains is directly activated by an interferon a-induced cytoplasmic protein tyrosine kinase(s). Cell. 70:1992;323-335.
26. Fu X.-Y., Schindler C., Improta T., Aebersold R., Darnell J.E. Jr. The proteins of ISGF-3: the interferon-α-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA. 89:1992;7840-7843.
27. Fu X.-Y., Zhang J.-J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell. 74:1993;1135-1145.
28. Greenlund A.C., Farrar M.A., Viviano B.L., Schreiber R.D. Ligand-induced IFN-gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system. EMBO J. 13:1994;1591-1600.
29. Gupta S., Yan H., Wong L.H., Ralph S., Krolewski J., Schindler C. The SH2 domains of Stat1 and Stat 2 mediate multiple interactions in the transduction of IFN-alpha signals. EMBO J. 5:1996;1075-1084.
30. Guyer N.B., Severns C.W., Wong P., Feghali C.A., Wright T.M. IFN-gamma induces a p91/Stat1 alpha-related transcription factor with distinct activation and binding properties. J. Immunol. 155:1995;179-186.
31. Haque S.J., Flati V., Deb A., Williams B.R.G. Roles of protein-tyrosine phosphotases in Stat1-alpha-mediated cell signaling. J. Biol. Chem. 270:1995;25709-25714.
32. Harpur A.G., Anders A.D., Ziemecki A., Aston R.R., Wilks A.F. A third member of the JAK family of protein tyrosine kinases. Oncogene. 7:1992;1347-1353.
33. Haspel R.L., Salditt-Georgieff M., Darnell J.E. Jr. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15:1996;6262-6268.
34. Heim M.H., Kerr I.M., Stark G.R., Darnell J.E. Jr. Contribution of STAT SH2 groups to specific interferon signaling by the JAK-STAT pathway. Science. 267:1995;1347-1349.
35. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
36. Hochstrasser M. Ubiquitin, proteasomes and the regulation of intercellular protein degradation. Curr. Opin. Cell. Biol. 7:1995;215-223.
37. Horvath C.M., Wen Z., Darnell J.E. Jr. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:1995;984-994.
38. Hou J., Schindler U., Henzel W.J., Ho T.C., Brasseur M., McKnight S.L. An interleukin-4-induced transcription factor: Il-4 Stat. Science. 265:1994;1701-1706.
39. Hou X.S., Melnick M.B., Perrimon N. Marelle acts downstream of the Drosophila HOP/JAK kinase andencodes a protein similar to the mammalian STAT's. Cell. 84:1996;411-419.
40. Ihle J.N. Cytokine receptor signaling. Nature. 377:1995;591-594.
41. Ihle J.N., Kerr I.M. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:1995;69-74.
42. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Ann. Rev. Immuno. 13:1995;369-398.
43. Improta T., Schindler C., Horvath C.M., Kerr I.M., Stark G.R., Darnell J.E. Jr. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc. Natl. Acad. Sci. USA. 91:1994;4776-4780.
44. Kahn K.D., Shuai K., Lindwall G., Maher S.E., Darnell J.E. Jr., Bothwell A.L.M. Induction of the Ly-6A/E gene by both interferon alpha/beta and gamma requires a DNA element to which a tyrosine phosphorylated 91 kDa protein binds. Proc. Natl. Acad. Sci. USA. 90:1993;6806-6810.
45. Kaplan M.H., Sun Y.L., Hoey T., Grusby M.J. Impaired IL-12 responses and enhanced development of TH2 cells in STAT4-deficient mice. Nature. 6587:1996;174-177.
46. Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell. Biol. 6:1994;415-424.
47. Kawata T., Shevchenko A., Fukuzawa M., Jermyn K.A., Totty N.F., Zhukovskaya N.V., Sterling A.E., Mann M., Williams J.G. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in dictyostelium. Cell. 89:1997;909-916.
48. Kessler D.S., Veals S.A., Fu X.-Y., Levy D.E. Interferon-alpha regulated nuclear translocation and DNA-binding affinity of ISGF-3, a multimeric transcriptional activator. Genes and Dev. 4:1990;1753-1765.
49. Kim T.K., Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science. 273:1996;1717-1719.
50. Kumar A., Commane M., Flickinger T.W., Horvath C.M., Stark G.R. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science. 278:1997;1630-1632.
51. Levy D.E., Kessler D.S., Pine R., Reich N., Darnell J.E. Jr. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative control. Genes Dev. 2:1988;383-393.
52. Levy D.E., Kessler D.S., Pine R.I., Darnell J.E. Jr. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha stimulated transcription, reconstituted in vitro. Genes Dev. 3:1989;1362-1372.
53. Liu, B., Liao, J., Rao, X., Kushner, S.A., Chung, C.D., Chang, D.D., Shuai, K., 1998. Inhibition of Stat-1 mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95, 10626-10631.
54. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshawq-Boris L. Stat5a is mandatory for adult mammary gland development and lactogenisis. Genes Dev. 11:1997;179-186.
55. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target ofthe JAK-STAT5 pathway and modulates Stat5 activation. Blood. 89:1997;3148-3154.
56. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D.et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:1996;431-442.
57. Mikita T., Campbell D., Wu P., Williamson K., Schindler U. Requirements for interleukin-4- induced gene expression and functional characterization of Stat6. Mol. Cell. Biol. 10:1996;5811-5820.
58. Minamoto S., Ikegame K., Ueno K., Narazaki M., Naka T., Yamamoto H., Matsumoto T., Saito H., Hosoe S., Kishimoto T. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 237:1997;79-83.
59. Morriggl R., Gouilleux-Gruart V., Jahne R., Berchtold S., Gartmann C., Lui X., Henningson L., Sotiropoulos A., Groner B., Gouilleux F. Deletion of the carboxl-terminal transactivation domain of MFG-StaT5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16:1996;5691-5700.
60. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J.E. Jr., Stark G.R., Kerr I.M. Complementation of a mutant cell line: Central role of the 91-kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathway. EMBO J. 12:1993;4221-4228.
61. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
62. Ng J., Cantrell D. Stat 3 is a serine kinase target in T-lymphocytes. Interleukin 2 and T-cell antigen receptor signals coverage uponserine 727. J. Biol. Chem. 272:1997;24542-24549.
63. Ohya K., Kajigaya S., Yamashita Y., Miyazato A., Hatake K., Miura Y., Ikeda U., Shimanda K., Ozawa K., Mano H. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J. Biol. Chem. 272:1997;27178-27182.
64. Onishi M., Nosaka T., Misawa K., Mui A.L.-F., Gorman D., McMahon M., Miyajima A., Kitamura T. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18:1998;3871-3879.
65. Pawson T., Schlessinger J. SH2 and SH3 domains. Curr. Biol. 3:1993;434-441.
66. Pawson T., Scott J.D. Signaling through scaffold, anchoring and adaptor proteins. Science. 278:1997;2075-2080.
67. Pellegrini S., John J., Shearer M., Kerr M., Stark G.R. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathways. Mol. Cell. Biol. 11:1989;4605-4612.
68. Pellegrini S., Dusanter F.I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 3:1997;615-633.
69. Pfeffer L.M., Mullersman J.E., Pfeffer S.R., Murti A., Shi W., Yang C.H. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science. 276:1997;1418-1420.
70. Pine R., Canova A., Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma and is likely to autoregulate the p91 gene. EMBO J. 13:1994;158-167.
71. Qureshi S.A., Leung S., Kerr I.M., Stark G.R., Darnell J.E. Jr. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol. Cell. Biol. 16(1):1996;288-293.
72. Rane S.G., Reddy E.P. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene. 9:1994;2415-2423.
73. Reich N., Evans B., Levy D.E., Fahey D., Knight E. Jr., Darnell J.E. Jr. Interferon-induced transcription of a gene encoding a 15 kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA. 84:1987;6394-6398.
74. Sadowski H.B., Shuai K., Darnell J.E. Jr., Gilman M.Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science. 261:1993;1739-1744.
75. Schindler C., Fu X.-Y., Improta T., Aebersold R., Darnell J.E. Jr. Proteins of transcription factor ISGF-3: one gene encodes the 91 and 84 kDa ISGF-3 proteins that are activated by interferon-alpha. Proc. Natl. Acad. Sci. USA. 89:1992;7836-7839.
76. Schindler C., Shuai K., Prezioso V.R., Darnell J.E. Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 257:1992;809-815.
77. Schindler C., Darnell J.E. Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann. Rev. Biochem. 64:1995;621-651.
78. Sengupta T.K., Schmitt E.M., Ivashkiv L.B. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc. Natl. Acad. Sci. USA. 93:1996;9499-94504.
79. Shuai K., Schindler C., Prezioso V.R., Darnell J.E. Jr. Activation of transcription by IFN-g: tyrosine phosphorylation of a 91 kD DNA binding protein. Science. 259:1992;1808-1812.
80. Shuai K., Stark G.R., Kerr I.M., Darnell J.E. Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science. 261:1993;1744-1746.
81. Shuai K., Ziemiecki A., Wilks A.F., Harpur A.G., Sadowski H.B., Gilman M.Z., Darnell J.E. Jr. Polypeptide signaling to the nucleus through tyrosine phosphorylation of JAK and STAT proteins. Nature. 366:1993;580-583.
82. Shuai K. Interferon-activated signal transduction to the nucleus. Curr. Opin. Cell. Biol. 6:1994;253-259.
83. Shuai K., Horvath C.M., Tsai-Huang L.H., Qureshi S., Cowburn D., Darnell J.E. Jr. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell. 76:1994;821-828.
84. Shuai K., Liao J., Song M.M. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol. Cell. Biol. 16:1996;4932-4941.
85. Starr R., Willson T.A., Viney E.M., Murray L.J.L., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
86. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signalling. Nature. 380:1996;627-630.
87. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruptionof the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:1997;3801-3804.
88. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinase. Science. 268:1995;251-255.
89. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat 5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
90. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., Sangster M.Y., Vignali D.A., Doherty P.C., Grosveld G.C., Ihle J.N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T-cells. Nature. 382:1996;171-174.
91. Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell. Biol. 8:1996;205-215.
92. Uddin S., Chamdin A., Platanias L.C. Interaction of the trascriptional activator Stat-2 with the type I interferon receptor. J. Biol. Chem. 270:1995;24627-24630.
93. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Ntnl. Acad. of Sci. of the US. 94:1997;7239-7244.
94. Valdez, B.C., Henning, D., Perlaky, L., Busch, R.K., Busch, H., 1997. Cloning and characterization of Gu/RH-11 binding protein. Biochem. Biophys. Res. Commun. 234, 335-340.
95. Veals S.A., Schindler C., Leonard D., Fu X.-Y., Aebersold R., Darnell J.E. Jr., Levy D.E. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding protein. Mol. Cell. Biol. 12:1992;3315-3324.
96. Velazquez L., Fellows M., Stark G.R., Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signalling pathway. Cell. 70:1992;313-322.
97. Vinkemeier U., Cohen S.L., Moarefi I., Chait B.T., Kuriyan J., Darnell J.E. Jr. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15:1996;5616-5626.
98. Vinkemeier U., Moarefi I., Darnell J.E. Jr., Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science. 279:1998;1048-1052.
99. Wakao H., Gouilleux F., Groner B. Mammary gland factor (MGF) is a nobel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13:1994;2182-2191.
100. Wang D., Stravopodis S., Teglund D., Kitazawa J., Ihle J.N. Naturally occuring dominant negative variants of Stat5. Mol. Cell. Biol. 16:1996;6141-6148.
101. Wen Z., Zhong Z., Darnell J.E. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
102. Wen Z., Darnell J.E. Jr. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucl. Acids Res. 25:1997;2062-2067.
103. + channel regulatory Protein, KChAP. J. Biol. Chem. 273:1998;11745-11751.
104. Wilks A.F. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:1989;1603-1607.
105. Wilks A.F., Harpur A., Kurlan R.R., Ralph S.J., Zurder G., Ziemiecki A. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain define a new class of protein kinase. Mol. Cell. Biol. 11:1991;2057-2065.
106. Wilks A.F., Oates A.C. The JAK/STAT pathway. Cancer Surveys. 27:1996;139-163.
107. Wong P., Sevewrns C.W., Guyerm N.B., Wright T.M. A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol. Cell. Biol. 155:1995;914-922.
108. Wu L., Wu H., Sangiorgi F., Wu N., Bell J.R., Lyons G.E., Maxson R. Miz1, a novel zing finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Devel. 65:1997;3-17.
109. Xu X., Sun Y.L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science. 273:1996;794-797.
110. Yamamoto K., Quelle F.W., Thierfelder W.E., Kreider B.L., Gilbert D.J., Jenkins N.A., Copeland N.G., Silvennoinen O., Ihle J.N. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol. Cell. Biol. 14:1994;4342-4349.
111. Yan H., Krishman K., Greenland A.C., Gupta S., Lim J.T., Schreiber R.D., Schindler C.W., Krolewski J.J. Phosphorylated interferon-alpha receptor 1 subunit IFNaR1 acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J. 15:1996;1064-1074.
112. Yan R., Small S., Desplan C., Dearolf C.R., Darnell J.E. Jr. Identification of a Stat gene that functions in Drosophila development. Cell. 84:1996;421-430.
113. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:1995;2816-2826.
114. Zhang J.J., Vinkemeier U., Gu W., Chakravarti D., Horvath C.M., Darnell J.E. Jr. Two contact regions between Stat1 and CBP/p300 in interferon g signaling. Proc. Natl. Acad. Sci. USA. 93:1996;15092-15096.
115. Zhang X., Blenis J., Li H.C., Schindler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 267:1995;1990-1994.
116. Zhong Z., Wen Z., Darnell J.E. Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264:1994;95-98.
117. Zhong Z., Wen Z., Darnell J.E. Jr. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. USA. 91:1995;4806-4810.